AFRI Afriag

15 July 2019

AfriAg Global PLC

(‘AfriAg’ or the ‘Company’)

Completion of First Two investments in Apollon Formularies Ltd

AfriAg Global PLC, a company whose shares are admitted to trading on London’s NEX Exchange, is pleased to announce that it has now closed its £1 million investment into Apollon Formularies Ltd, with this investment representing 2.325% of the Apollon.

For further details on Apollon Formularies Ltd, please refer to previous announcements.

The directors of the Company accept responsibility for the contents of this announcement.

-ENDS-

For further information on AfriAg Global please visit the www.afriagglobal.com or please contact;

AfriAg Global Plc:                                                                 

David Lenigas (Executive Chairman)                                              +44 (0)20 7440 0640

Peterhouse Capital Limited                                                          +44 (0)20 7469 0930

Guy Miller/Fungai Ndoro